South Sudan: President Salva Kiir jabbed with AstraZeneca vaccine!

Spread the news

On Tuesday afternoon, President Salva Kiir of South Sudan received his first AstraZeneca vaccine. In recent weeks, there have been several controversies about the vaccine’s safety and effectiveness. 

President Barack Obama received the vaccine on Tuesday, according to Presidential Affairs Minister Barnaba Marial Benjamin, so that he could set an example that the vaccine is safe and that people can expect it. 

“We need to take this injection which has been taken by millions of people across the world. “We are not the first ones to be jabbed with it. And we admit that there are some risks in it but there are more when you are not injected,” he said. 

Mr Marial urged people to get Covid-19 vaccinations. They obtained 132,000 doses of the AstraZeneca Covid-19 vaccine in late March. This is the first of many vaccine shipments expected to arrive at the Covax facility in the coming months.

Data source: Nation Africa

TOA Correspondent

Recent Posts

The top Nigerian who hated his own voice

Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…

3 years ago

South African court halts Amazon HQ project

Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…

3 years ago

How Digitalization in African Rail Transportation Is Enhancing Safety?

Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…

3 years ago

Tunisian leader to allow public views on reforms

Kais Saied, the Tunisian president has said in his speech that he will allow the…

3 years ago

The power of Niacinamide in the trending African skincare market

You know the credibility of an ingredient when it’s plastered all over bottles and jars…

3 years ago

Mozambique death toll from Cyclone Gombe rises to 48

Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…

3 years ago

This website uses cookies.